What is Alidya®?
THE FIRST INJECTABLE DEVICE particularly suitable for the prevention and treatment of gynoid lipodystrophy (cellulite)
AlidyaTM is the first injectable device specifically indicated for the prevention and treatment of gynoid lipodystrophy (cellulite). Originating from studies conducted by Prof. Pasquale Motolese, which identified as a contributory factor in the genesis of cellulite, the presence of extracellular toxic ions, deposited following alterations of the vascular microcirculation.
The action of AlidyaTM is expressed by the solubilization, and as a consequence of the
removal of these extracellular toxic elements, as well as the restoration of normal cell omeostasis, translates clinically in the improvement of the area affected or predisposed to the development of cellulite.
- A polyamino acid gel
- D-(+) Alpha-D-glucopyranose
- 1-4 glucosidico
- Sodium ethylenediaminetetraacetic
- Amino acid buffer system with sodium bicarbonate corrector
- Osmolarity regulator
The product is provided in a package with 5 vials, each containing 340 mg of powder and 5 vials with 10 ml of solvent.